Sales rise 55.55% to Rs 715.59 crore
Net profit of ERIS Lifesciences declined 12.31% to Rs 83.18 crore in the quarter ended June 2024 as against Rs 94.86 crore during the previous quarter ended June 2023. Sales rose 55.55% to Rs 715.59 crore in the quarter ended June 2024 as against Rs 460.03 crore during the previous quarter ended June 2023.
ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales715.59460.03 56 OPM %34.9336.90 –PBDT191.26153.38 25 PBT115.32112.49 3 NP83.1894.86 -12
Powered by Capital Market – Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Aug 02 2024 | 3:14 PM IST
